Correo: bd@sidmexinovia.com
Teléfono: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inicio >
Mylimus 1.0mg Capsule
Mylimus 1.0mg Capsule
Manufacturer/Marketed By : MYLAN PHARMACEUTICALS PVT LTD
$4.12 $2.83
Mylimus 1mg Capsule contains the active substance Tacrolimus. It is an immunosuppressant that belongs to the class of medications called calcineurin inhibitors. This capsule is used along with other medications...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
TACROLIMUS
Active Pharmaceutical Ingredient
Mylimus 1.0mg Capsule
4,12 US$
2,83 US$
Mylimus 1mg Capsule contains the active substance Tacrolimus. It is an immunosuppressant that belongs to the class of medications called calcineurin inhibitors. This capsule is used along with other medications to prevent organ transplant rejection in people receiving liver, kidney, heart, or other transplants. It is also indicated to control your body’s immune response, enabling it to accept the transplanted organ. Do not take this Mylimus 1mg Capsule if you are allergic to tacrolimus or any of the other ingredients of this medicine. Report your physician if you are allergic to any antibiotic group. Inform your doctor if you have or had a liver or heart disease before initiating the treatment. Notify your physician immediately if you develop fever, bruising under the skin (which may appear as red dots), unexplained tiredness, confusion, yellowing of the skin or eyes, reduced urine output, vision loss, and seizures after taking this medicine. Limit exposure to sunlight and UV light while consuming Mylimus 1mg Capsule by wearing appropriate protective clothing and sunscreen with a high sun protection factor. This is because of the potential risk of malignant skin changes with immunosuppressive therapy. This medicine may cause diarrhea; inform your physician if you have diarrhea for over a day. If you need to receive any vaccinations, consult your doctor once before receiving them.
Active Pharmaceutical Ingredient
Usos
• Prevent organ transplant rejections.
Beneficios
Tacrolimus in Mylimus 1mg Capsule causes immunosuppression by inhibiting T-lymphocyte activation and proliferation of T-helper-cell-dependent B-cell response. It works by attaching to a protein called FKBP-12 and forms a complex called tacrolimus-FKBP, which inhibits the action of calcineurin phosphatase. This, in turn, inhibits the formation of T cells and suppresses the immune response.
Efectos secundarios
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Efectos secundarios más comunes
• Increased or decreased heartbeats
• GI bleeding
• Liver Injury
• Seizure
• Acute kidney failure
• Lung infection or respiratory problems
Efectos secundarios comunes
• Swelling in the arm or leg
• Hair loss
• Itchy skin
• Constipation, diarrhea
• Nausea, vomiting
• Anemia
• Headache
• Cough
Cómo utilizar
Your doctor will decide the dose and duration of the treatment based on your disease condition, severity, and other factors. Always take Mylimus 1mg Capsule as prescribed by your doctor. Do not open, break, crush, or chew the capsules. Swallow the capsule whole with a glass of water. Take these capsules on an empty stomach or at least 1 hour before or 2 to 3 hours after the meal.
Safety Advice
• Breast Feeding: Do not consume Mylimus 1mg Capsule if you are breastfeeding because this medicine is excreted into breast milk and may cause harmful effects on the body.
• Alcohol: It is unsafe to consume alcohol when taking Mylimus 1mg Capsule because it may cause excessive drowsiness or liver problems.
• Liver: Mylimus 1mg Capsule should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary for severe liver failure. Inform your doctor if you have liver problems before initiating the therapy.
• Lungs: It is unknown whether Mylimus 1mg Capsule can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Driving vehicles or operating machinery while taking Mylimus 1mg Capsule is unsafe because it may cause drowsiness and vision problems.
• Pregnancy: Based on animal studies, Mylimus 1mg Capsule can cause harmful effects on the baby. Inform your physician if you are pregnant, suspecting pregnancy or planning to get pregnant before initiating the treatment.
Descargo de responsabilidad
Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.
Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.
Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.
Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.